These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke. Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437 [TBL] [Abstract][Full Text] [Related]
12. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model. Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023 [TBL] [Abstract][Full Text] [Related]
14. Vascular protection and restorative therapy in ischemic stroke. Yamashita T; Deguchi K; Nagotani S; Abe K Cell Transplant; 2011; 20(1):95-7. PubMed ID: 20887680 [TBL] [Abstract][Full Text] [Related]
15. Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it before. Tymianski M Stroke; 2010 Oct; 41(10 Suppl):S87-90. PubMed ID: 20876514 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic management of ischemic stroke: relevance to stem cell therapy. Gilman S Exp Neurol; 2006 May; 199(1):28-36. PubMed ID: 16631744 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotection via AT Bennion DM; Steckelings UM; Sumners C Clin Sci (Lond); 2018 May; 132(10):1055-1067. PubMed ID: 29802210 [TBL] [Abstract][Full Text] [Related]